Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Menostar vs Raloxifene for Osteoporosis Prevention
NCT00310531Phase 3Completed
- Sponsor
- Bayer
- Start
- Feb 2004
- Modality
- Hormone, Biologic
01
Overview
A Phase 3 trial of estradiol in osteoporosis, sponsored by Bayer. Started Feb 2004; status: completed.
02
Drugs
estradiol
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00310531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00310531.